Olaparib Out: AstraZeneca Withdraws Key Cancer Drug for Advanced Cases

Unknown Apr 02, 2026 1 Views

AstraZeneca Pharma India Ltd has relinquished its marketing authorization for Olaparib tablets (traded as Lynparza) for certain cancer indications in India. This action comes after a directive from the Drug Controller General of India (DCGI) to take the drug off the market for certain patient pop...